Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruvolo

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Blood|June 9, 2016
Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemiaSujan Piya, Steven M Kornblau, Vivian R Ruvolo, et al.
BBA Clinical|December 18, 2015
Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patientsPeter P Ruvolo, YiHua Qiu, Kevin R Coombes, et al.
Cytoskeleton (Hoboken, N.J.)|May 28, 2015
Xenopus TACC1 is a microtubule plus-end tracking protein that can regulate microtubule dynamics during embryonic developmentChristopher M Lucaj, Matthew F Evans, Belinda U Nwagbara, et al.
Biochimica Et Biophysica Acta|December 26, 2015
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cellsPeter P Ruvolo, Vivian R Ruvolo, Christopher B Benton, et al.
Ebiomedicine|May 21, 2019
LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AMLPeter P Ruvolo, Chenyue W Hu, Yihua Qiu, et al.
Haematologica|September 16, 2017
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanismsPeter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 17, 2013
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLP Y Mak, D H Mak, H Mu, et al.
Cell Death and Differentiation|April 28, 2007
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1Y Tabe, L Jin, R Contractor, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Blood|June 9, 2016
Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemiaSujan Piya, Steven M Kornblau, Vivian R Ruvolo, et al.
BBA Clinical|December 18, 2015
Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patientsPeter P Ruvolo, YiHua Qiu, Kevin R Coombes, et al.
Cytoskeleton (Hoboken, N.J.)|May 28, 2015
Xenopus TACC1 is a microtubule plus-end tracking protein that can regulate microtubule dynamics during embryonic developmentChristopher M Lucaj, Matthew F Evans, Belinda U Nwagbara, et al.
Biochimica Et Biophysica Acta|December 26, 2015
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cellsPeter P Ruvolo, Vivian R Ruvolo, Christopher B Benton, et al.
Ebiomedicine|May 21, 2019
LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AMLPeter P Ruvolo, Chenyue W Hu, Yihua Qiu, et al.
Haematologica|September 16, 2017
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanismsPeter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Apoptosis : an International Journal on Programmed Cell Death|December 17, 2013
Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AMLP Y Mak, D H Mak, H Mu, et al.
Cell Death and Differentiation|April 28, 2007
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1Y Tabe, L Jin, R Contractor, et al.
Leukemia|November 9, 2011
MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexM Konopleva, M Milella, P Ruvolo, et al.
Pageof 9